Tratamento da Fase Aguda do Acidente Vascular Cerebral Isquêmico
DOI:
https://doi.org/10.34024/rnc.2005.v13.8844Palavras-chave:
Acidente Vascular Cerebral, Tratamento da fase aguda, Trombólise, R-TPAResumo
O tratamento da fase aguda do acidente vascular cerebral isquêmico (AVCi) inclui a preservação da zona de penumbra isquêmica, o tratamento das complicações clínicas decorrentes do AVCi e a tentativa de determinação do mecanismo fisiopatológico responsável pelo evento. A abordagem do paciente na fase aguda do AVCi será o assunto desse artigo de revisão incluindo a terapia trombolítica e o tratamento de pacientes não candidatos à trombólise.
Downloads
Métricas
Referências
European Stroke Initiative Recommendations for Stroke Management - Update 2003: The European Stroke Initiative Executive Committee andthe EUSI Writing Committee. Cerebrovascular Diseases2003; 16:311-337.
Adams H, Adams R, Zoppo GD, Goldstein LB. Guidelines for the Early Management of Patients With Ischemic Stroke: 2005 Guidelines Update: A Scientific Statement From the Stroke Council of the American Heart Association/American Stroke Association. Stroke2005; 36:916-923.
Brott T, Reed RL. Intensive care for acute stroke in the community hospital setting. The first 24 hours. Stroke 1989;20:694–697.
Schellinger PD, Fiebach JB, Hacke W. Imaging-based decision making in thrombolytric therapy for ischemic stroke – Present state. Stroke 2003; 34:575–583.
Alexandrov AV, Molina CA, Grotta JC,et al.Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N EnglJ Med 2004; 351: 2170-2178.
Ronning OM, Guldvog B. Should stroke victims routinely receive supplemental oxygen? A quasi-randomized controlled trial. Stroke 1999;30:2033–2037.
Berrouschot J, Rossler A, Koster J, Schneider D. Mechanical ventilation in patients with hemispheric ischemic stroke. Crit Care Med 2000;28:2956–2961.
Broderick JP, Phillips SJ, O’Fallon WM, Frye RL, Whisnant JP. Relationship of cardiac disease to stroke occurrence, recurrence, and mortality. Stroke 1992;23:1250–1256.
Fukuda H, Kitani M, Takahashi K. Body temperature correlates with functional outcome and the lesion size of cerebral infarction. Acta Neurol Scand 1999;100:385–390.
Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: Asystematic overview. Stroke 2001;32:2426–3223.
Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: Asystematic overview. Stroke 2001;32:2426–3223.
Schrader J, Luders S, Kulschewski A et al. Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group. The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke. 2003;34: 1699–1703.
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (NINDS): Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–1587.
Hacke W, Brott T, Caplan L et al. Thrombolysis in acute ischemic stroke: Controlled trials and clinical experience. Neurol 1999;53(7 suppl 4):S3–S14.
Hacke W, Donnan G, Fieschi C et al. ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rtPA stroke trials. Lancet. 2004;363:768–774.
Hsia AW, Sachdev HS, Tomlinson J, Hamilton SA, Tong DC. Efficacy of IV tissue plasminogen activator in acute stroke: does stroke subtype really matter? Neurol. 2003;61:71–75.
The Multicenter Acute Stroke Trial – Europe Study Group: Thrombolytic therapy with streptokinase in acute ischaemic stroke. N Engl J Med 1996;335:145–150.
Hacke W, Albers G, Al-Rawi Y, et al.The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9- hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005; 36: 66-73.
Lisboa R, Jovanovic B, Alberts MJ. Analysis of the safety and efficacy of intra-arterial thrombolytic therapy in ischemic stroke. Stroke. 2002;33:2866–2871.
Brandt T, von Kummer R, Müller-Küppers M, Hacke W. Thrombolyic therapy of acute basilar artery occlusion: Variables affecting recanalization and outcome. Stroke 1996;27:875–881.
Gobin YP, Starkman S, Duckwiler GR, et al. MERCI 1: a phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke. 2004;35:1–6.
Brainin M, Bornstein N, Boysen G, Demarin Vfor the EFNS Task Force on Acute Neurological Stroke Care: Acute neurological stroke care in Europe: results of the European stroke care inventory. Eur J Neurol 2000;7:5–10.
Brainin M, Bornstein N, Boysen G, Demarin V for the EFNS Task Force on Acute Neurological Stroke Care: Acute neurological stroke care in Europe: results of the European stroke care inventory. Eur J Neurol 2000;7:5–10.
Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, Haley EC, Grotta J, Marler J: Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke 1994;25:2220–2226.
International Stroke Trial Collaborative Group: The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet 1997: 349:1569-1581.
Kay R, Wong KS, Yu YL. Low molecular weight heparin for the treatment of acute ischaemic stroke. New Engl J Med 1995;333:1588–1593.
Hommel M, for the FISS bis Investigators group: Fraxiparin in acute ischaemic stroke. Cerebrovasc Dis 1998;8: 63.
The TOAST Publication Committee: Low molecular weight heparinoid, ORG 10172 and outcome after acute ischemic stroke. JAMA 1998;279:1265–1272.
Chamorro ª Immediate anticoagulation in acute focal brain ischemia revisited: Gathering the evidence. Stroke 2001;32:577–578.
The Hemodilution in Stroke Study Group: Hypervolemic hemodilution treatment of acute stroke: Results of a randomized multicenter trial using pentastarch. Stroke 1989;20:317–323.
Strand T. Evaluation of long-term outcome and safety after hemodilution therapy in acute ischemic stroke. Stroke 1992;23:657–662.
Muir KW, Lees KR, Ford I, Davis S. Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet. 2004;363:439–445.
Davalos A, Castillo J, Alvarez-Sabín J et al. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke. 2002;33:2850–2857.
Davenport RJ, Dennis MS, Wellwood I, Warlow CP. Complications after acute stroke. Stroke 1996;27:415–420.
Horner J, Massey E, Riski J, et al. Aspiration following stroke: Clinical correlates and outcome. Neurol 1988;38:1359–1362.
Silver F, Norris J, Lewis A, Hachinski V. Early mortality following stroke: A prospective review. Stroke 1984;15: 492–496.
Olsen TS. Post-stroke epilepsy. Curr Atheroscler Rep 2001;3:340–344.
Davalos A, Toni D, Iweins F, Lesaffre E, Bastianello S, Castillo J. Neurological deterioration in acute ischemic stroke: Potential predictors and associated factors in the European cooperative acute stroke study (ECASS). Stroke 1999;30:2631–2636.
Righetti E, Celani MG, Cantisani TA, Sterzi R, Boysen G, Ricci S. Glycerol for acute stroke: A Cochrane systematic review. J Neurol 2002;249:445–451.
Bereczki D, Liu M, do Prado GF, Fekete I. Mannitol for acute stroke. Cochrane Database Syst Rev 2001;(1):CD001153.
Schwarz S, Schwab S, Bertram M, Aschoff A, Hacke W. Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke 1998;29:1550–1555.
Qizilbash N, Lewington SL, Lopez-Arrieta JM. Corticosteroids for acute ischaemic stroke. Cochrane Database Syst Rev 2002;(2):CD000064.
Bernard SA, Gray TW, Buist MD et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002;346:557–563.
Schwab S, Steiner T, Aschoff A, et al. Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke 1998;29:1888–1893.
Rieke K, Schwab S, Krieger D et al. Decompressive surgery in space-occupying hemispheric infarction: Results of an open, prospective trial. Crit Care Med 1995;23:1576–1587.
Kastrau F, Wolter M, Huber W, Block F. Recovery From Aphasia After Hemicraniectomy for Infarction of the Speech-Dominant Hemisphere. Stroke 2005;. 36: 825-829.
Mori K, Aoki A, Yamamoto T, Maeda M. Aggressive decompressive surgery in patients with massive hemispheric embolic cerebral infarction associated with severe brain swelling. Acta Neurochir (Wien) 2001;143: 483–492.
Downloads
Publicado
Como Citar
Edição
Seção
Publicado: 2005-03-31
Português
English
Español
